Sulfur burps on GLP-1s: why they happen and what helps
Sulfur burps on Wegovy and Zepbound are real but unmeasured. Here is what labels, reviews and belching guidance show, and what is only a guess.
GoGLP1 earns a commission from qualifying provider enrollments via links on this page. This never affects our editorial rankings or reviews. Full disclosure.
Rotten-egg burps are a familiar complaint among people taking semaglutide and tirzepatide. They’re also a gap in the evidence. No trial I found measured sulfur burps, hydrogen sulfide in belched gas, or any fix for belching in people on GLP-1 drugs.
What exists is narrower. Drug labels record belching (eructation) as a general adverse reaction. Separate research describes how gut bacteria make sulfur gas. General medical guidance covers belching in the broader population. Connect those pieces and you have inference, not proof.
This article separates what’s documented from what’s hypothesis, and shows what the usual advice actually rests on.
What the trials actually recorded
Trials did not code “sulfur burps.” They coded eructation, the medical term for belching. The label data says nothing about odor.
Wegovy (semaglutide 2.4 mg)
The Wegovy label lists eructation among adverse reactions more common than placebo. In the pooled adult weight-management trials (68 weeks, placebo-controlled, 2,116 Wegovy and 1,261 placebo patients), the rates were:
| Reaction | Wegovy | Placebo |
|---|---|---|
| Eructation | 7% | <1% |
| Flatulence | 6% | 4% |
| Abdominal distension | 7% | 5% |
| GERD | 5% | 3% |
Zepbound (tirzepatide)
The Zepbound label reports pooled placebo-controlled weight-reduction trials (Studies 1 and 2). Placebo had 958 patients. The 5 mg, 10 mg and 15 mg groups had 630, 948 and 941.
| Reaction | Placebo | 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| Eructation | 1% | 4% | 5% | 5% |
| Flatulence | 2% | 3% | 3% | 4% |
| GERD | 2% | 4% | 4% | 5% |
How far to trust these numbers
Not far, if you want drug-to-drug comparisons. The labels give whole-number percentages from pooled trials, so a 7% rate could be 6.5% or 7.4%. The two drugs were studied in different populations, at different doses, over different periods. Comparing eructation rates between Wegovy and Zepbound with any precision isn’t possible.
The safe reading is limited: belching beat placebo in both programs. Neither label says how many of those belches smelled of sulfur.
Why it might happen: the hypothesis
The explanation you’ll see most often runs like this. GLP-1 drugs slow digestion. Food sits longer. Bacteria ferment it longer. More hydrogen sulfide (H2S), the rotten-egg gas, gets released. It comes up as a burp.
Not every link in that chain has the same support.
Link 1: slowed gastric emptying is documented, with limits
The Zepbound label states that tirzepatide delays gastric emptying, with the delay largest after the first dose and diminishing over time. The Wegovy label says semaglutide delays gastric emptying too. It also notes a separate study that found no apparent effect on gastric emptying rate with semaglutide 2.4 mg.
A narrative review in the Journal of Clinical Endocrinology & Metabolism adds two cautions. Tolerance (tachyphylaxis) develops to the gastric-slowing effect of long-acting GLP-1 receptor agonists with continued exposure. And GI symptoms such as nausea, vomiting or belching can’t be used to diagnose or exclude delayed gastric emptying; most studies find weak or absent correlation between measured emptying delay and symptoms.
So slowed emptying is a plausible contributor to belching and gas, not a confirmed driver of any given person’s symptoms. For more label language on this topic, see our explainer on GLP-1 drugs, gastroparesis and the FDA label.
Link 2: gut bacteria make H2S, in everyone
This part is well established, but in general populations, not GLP-1 users. Gut bacteria produce H2S by two main routes: dissimilatory sulfate reduction, carried out by bacteria such as Desulfovibrio and Bilophila, and degradation of sulfur-containing amino acids such as cysteine.
A Frontiers in Microbiology analysis examined 4,644 bacterial genomes, 10,700 metagenomic samples and 736 metatranscriptomic samples. It found putative cysteine-degrading bacteria in 100% of 6,623 healthy subjects. Those bacteria were significantly more abundant than sulfate reducers (p < 2.2e-16).
In plain terms: the machinery for making rotten-egg gas lives in essentially every healthy gut. Whether GLP-1 drugs change how much gets made is a separate question, and an unanswered one.
Link 3: the connection is unproven
I found no study showing that GLP-1 or GIP/GLP-1 drugs increase gut H2S production or change sulfate-reducing bacteria. The idea that slower digestion lets food ferment longer and release more sulfur gas is a reasonable hypothesis. It is not an established mechanism.
Other explanations haven’t been tested against sulfur burps either. The label data shows reflux (GERD) is more frequent on both drugs. Changes in how much and how fast people eat on these drugs could matter too. Those are open questions, not findings.
Does it fade over time?
Possibly. Don’t count on it.
Two label facts point that way. The Zepbound label says the gastric-emptying delay is largest after the first dose and diminishes over time. The Wegovy label reports gastrointestinal adverse reactions in 73% of Wegovy-treated patients versus 47% on placebo, with severe GI reactions in 4.1% versus 0.9%, and says these reactions were most frequent during dose escalation.
That supports a general pattern: GI effects cluster around starting the drug and stepping up the dose. Neither label addresses how long belching lasts, and the evidence on sulfur burps specifically doesn’t exist. If yours persist well past a dose change, tell your prescriber.
What the evidence says helps
Here’s the honest summary. Every remedy below comes from general belching guidance or from reasoning about mechanism. None has been tested in people on GLP-1 drugs.
Behavioral measures from major clinics
Cleveland Clinic says swallowing air is the most common cause of excessive belching. Eating or drinking too quickly and talking while eating are examples. It lists GERD as a medical cause. Its prevention advice:
- Avoid carbonated drinks.
- Avoid gas-producing foods.
- Eat slowly while seated.
Mayo Clinic’s guidance lists the same behavioral steps: eat and drink slowly, avoid carbonated drinks and beer, skip gum and hard candy, and don’t smoke.
Neither page mentions sulfur odor or GLP-1 medications. These are recommendations for the general population, aimed at swallowed air. Swallowed air wouldn’t explain a smell by itself, so these steps may cut the number of burps without changing what they smell like.
Simethicone
Mayo states that simethicone products (Gas-X, Mylanta Gas and others) have not been proved helpful, although many people feel they work. Caveat: that wording comes from a search excerpt of the Mayo page. I couldn’t load the page itself, so check the current text. Nothing suggests simethicone has been tested for belching on GLP-1 drugs.
Reflux
GERD is a recognized cause of excessive belching, and it runs more frequent on both drugs in the labels (Wegovy 5% versus 3% on placebo; Zepbound 4% to 5% versus 2%). A literature review on belching in GERD is available. Whether treating reflux reduces belching specifically in GLP-1 users hasn’t been tested in the sources I found. If you have heartburn along with the burps, mention both to your clinician.
Diet changes aimed at sulfur
Cutting dietary sulfur, trying probiotics, or following a low-FODMAP diet are popular suggestions. They follow from the gut-bacteria reasoning above. For GLP-1 users they’re untested. I wouldn’t call any of them proven, and I wouldn’t start a restrictive diet on a hunch while you’re already eating less. Plan the food side carefully: our protein protocol for avoiding muscle loss covers why intake matters on these drugs.
What nobody knows yet
- How often sulfur burps occur on GLP-1 drugs. The JAMA research letter by Sodhi and colleagues (2023) used health claims data to compare GLP-1 receptor agonists for weight loss with bupropion-naltrexone. It looked at four outcomes: biliary disease, pancreatitis, bowel obstruction and gastroparesis. It did not look at belching or sulfur burps, and none of the other sources I opened analyzed them either.
- Whether GLP-1 drugs change gut H2S production.
- Whether any remedy works for this symptom in this group.
Frequently Asked Questions
Are sulfur burps an official side effect of Wegovy, Ozempic, Zepbound or Mounjaro?
Not as a named term. FDA labels list eructation (belching) as more common than with placebo: Wegovy 7% versus <1%, Zepbound 4% to 5% versus 1%. The odor is not captured in trial data.
Why might GLP-1 medications cause rotten-egg burps?
The leading hypothesis is slower gastric emptying plus gut-bacteria H2S production from sulfur-containing foods. The labels confirm delayed gastric emptying, but no study links it to H2S-smelling belches. The Wegovy label also cites a study that found no apparent effect of the 2.4 mg dose on emptying rate. Treat the mechanism as a hypothesis, not a fact.
Does it go away over time?
It may ease, but that’s not guaranteed. The Zepbound label says the gastric-emptying delay is largest after the first dose and diminishes over time. The Wegovy label says GI reactions are most frequent during dose escalation. Neither addresses how long belching lasts.
What can I do about it?
The evidence is general belching advice from Mayo Clinic and Cleveland Clinic, not GLP-1 trials. Eat slowly. Avoid carbonated drinks, gum and hard candy. Don’t talk while eating. Limit gas-producing foods. Mayo says simethicone is unproven. Cutting dietary sulfur is plausible but untested in this group. No remedy has been shown to work for GLP-1 users.
When should I call my doctor?
Per Cleveland Clinic, contact a provider if belching persists or comes with fever, abdominal pain, unexplained weight loss, fatigue, vomiting or diarrhea. The Wegovy label reports severe GI reactions in 4.1% of patients versus 0.9% on placebo. Talk to your prescriber before changing a dose or stopping the drug. Scheduled for a procedure? Read our piece on GLP-1 drugs and pre-surgery fasting guidance.
Bottom line
Belching is a documented, placebo-exceeding effect of both semaglutide and tirzepatide, at roughly 7% and 4% to 5% in the label trials. Sulfur burps are a plausible subset, but nobody has measured them. The slow-digestion explanation is a hypothesis. The fixes are borrowed from general belching advice. Use them as low-risk habits, not proven treatments, and get persistent or worsening symptoms evaluated.
This article is for informational purposes only and is not medical advice. Talk to your healthcare provider before starting, stopping, or changing any medication.
Ready to start?
Our top-rated GLP-1 providers, reviewed and tested. We may earn a commission — see our editorial policy.
Affiliate disclosure: GoGLP1 earns a commission from qualifying enrollments. This never affects our rankings or reviews. Reviewed 2026.